Health adapted for children and young people (ICF-CY) is a framework for describing and classifying health and health-related states. The aim of the present study was to review literature on neurofibromatosis type 1 (NF1) using ICF-CY guidelines and to highlight findings about the quality of life of children with NF1.METHOD Electronic databases were searched to identify studies involving children with NF1.Eligible studies were classified according to ICF-CY categories.RESULTS Children with NF1 have a variety of cognitive and other deficits. However, very little information is available on the impact of these deficits on their daily life.
Introduction
Fine motor and graphomotor skills are essential for children’s healthy development, as well as for successful participation in everyday activities. The Gilboa functional test (GIFT) is a newly developed norm-referenced screening instrument for use with children 3–6 years old. The aim of this study was to develop and validate the GIFT as a new measure for preschool graphomotor screening.
Method
A community-based sample of 611 children aged 3–6 years was screened.
Findings
Content validity was established via a panel of experts. The GIFT demonstrated good test–retest (0.95) and inter-rater reliability (0.94), demonstrating good concurrent validity in scores which significantly correlated with the Beery-VMI (r = 0.32, P < 0.05), the Beery-MC (r = 0.33, P < 0.05), the ‘manual dexterity’ subcategory of the movement assessment battery for children (r = –0.364, P < 0.05) and the total score of the developmental coordination disorder questionnaire ’07 (DCDQ’07)/little DCDQ (r = 0.41, P < 0.01). A significant difference in total GIFT scoring was found between children from mainstream versus special education preschools (t = 3.99, P < 0.001).
Conclusion
The GIFT is a unique tool that measures performance skills based on preschool children’s everyday activities. It can be used by paediatric occupational therapists as a first step for early identification of children potentially at risk for graphomotor/fine motor developmental delay.
Background
People with Parkinson’s disease (PwP) may experience gait impairment and freezing of gait (FOG), a major cause of falls. External cueing, including visual (e.g., spaced lines on the floor) and auditory (e.g., rhythmic metronome beats) stimuli, are considered effective in alleviating mobility deficits and FOG. Currently, there is a need for a technology that delivers automatic, individually adjusted cues in the homes of PwP. The aims of this feasibility study were to describe the first step toward the development of a home-based technology that delivers external cues, test its effect on gait, and assess user experience.
Methods
Iterative system development was performed by our multidisciplinary team. The system was designed to deliver visual and auditory cues: light stripes projected on the floor and metronome beats, separately. Initial testing was performed using the feedback of five healthy elderly individuals on the cues’ clarity (clear visibility of the light stripes and the sound of metronome beats) and discomfort experienced. A pilot study was subsequently conducted in the homes of 15 PwP with daily FOG. We measured participants' walking under three conditions: baseline (with no cues), walking with light stripes, and walking to metronome beats. Outcome measures included step length and step time. User experience was also captured in semi-structured interviews.
Results
Repeated-measures ANOVA of gait assessment in PwP revealed that light stripes significantly improved step length (p = 0.009) and step time (p = 0.019) of PwP. No significant changes were measured in the metronome condition. PwP reported that both cueing modalities improved their gait, confidence, and stability. Most PwP did not report any discomfort in either modality and expressed a desire to have such a technology in their homes. The metronome was preferred by the majority of participants.
Conclusions
This feasibility study demonstrated the usability and potential effect of a novel cueing technology on gait, and represents an important first step toward the development of a technology aimed to prevent FOG by delivering individually adjusted cues automatically. A further full-scale study is needed.
Trial registration This study was registered in ClinicalTrials.gov at 1/2/2022 NCT05211687.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.